Detailed insights into TOP1-DPCR at the organism level are important for biomedicine, because TOP1-DPC inducers, the CPT derivatives irinotecan and topotecan, are used to treat various cancers including ovarian and colon cancers, small-cell lung cancer, central nervous system tumours and sarcomas [69]. Here, TOP1 is linked to malignant colon neoplasm.